Literature DB >> 16854357

[Urinary tract infection in pregnancy].

Miguel Angel Herráiz1, Antonio Hernández, Eloy Asenjo, Ignacio Herráiz.   

Abstract

Urinary tract infections, asymptomatic bacteriuria (AB), acute cystitis (AC) and acute pyelonephritis (AP), are favored by the morphological and functional changes involved in pregnancy. AB increases the risk of preterm labor, low birth weight and AP. AB should be detected by uroculture (other methods are not sufficiently effective) and treated early. Approximately 80% of cases are caused by Escherichia coli. The risks and effectiveness of the distinct antibiotic regimens should be evaluated: fosfomycin trometamol in monotherapy or as short course therapy is safe and effective for the treatment of AB and AC. AP is the most frequent cause of hospital admission for medical reasons in pregnant women and can lead to complications in 10% of cases, putting the lives of the mother and fetus at risk. Currently outpatient treatment of AP is recommended in selected cases. Adequate follow-up of pregnant women with urinary tract infections is required due to frequent recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16854357     DOI: 10.1157/13091447

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  Vaginal and oral microbes, host genotype and preterm birth.

Authors:  Usha Srinivasan; Dawn Misra; Mary L Marazita; Betsy Foxman
Journal:  Med Hypotheses       Date:  2009-12       Impact factor: 1.538

2.  [Evaluation of Sysmex UF-1000i® flow cytometer as a screening method for asymptomatic bacteriuria and detection of Group B Streptococcus in pregnancy].

Authors:  I Angulo López; M Urrutikoetxea-Gutiérrez; J Aragón-Díez; M Fraca Padilla; J L Díaz de Tuesta Del Arco
Journal:  Rev Esp Quimioter       Date:  2020-05-11       Impact factor: 1.553

3.  Bacterial sensitivity to fosfomycin in pregnant women with urinary infection.

Authors:  Rodrigo Batista Souza; Daisson José Trevisol; Fabiana Schuelter-Trevisol
Journal:  Braz J Infect Dis       Date:  2015-01-24       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.